People with type 2 diabetes mellitus have increased risk of chronic kidney disease and atherosclerotic cardiovascular disease. Improved care delivery and implementation of guideline-directed medical therapy have contributed to the declining incidence of atherosclerotic cardiovascular disease in high-income countries. By contrast, the global incidence of chronic kidney disease and associated mortality is either plateaued or increased, leading to escalating direct and indirect medical costs. Given limited resources, better risk stratification approaches to identify people at risk of rapid progression to end-stage kidney disease can reduce therapeutic inertia, facilitate timely interventions and identify the need for early nephrologist referral. Among people with chronic kidney disease G3a and beyond, the kidney failure risk equations (KFRE) have been externally validated and outperformed other risk prediction models. The KFRE can also guide the timing of preparation for kidney replacement therapy with improved healthcare resources planning and may prevent multiple complications and premature mortality among people with chronic kidney disease with and without type 2 diabetes mellitus. The present review summarizes the evidence of KFRE to date and call for future research to validate and evaluate its impact on cardiovascular and mortality outcomes, as well as healthcare resource utilization in multiethnic populations and different healthcare settings.
Citations
Citations to this article as recorded by
Integrated SERS-magnetic capture platform for multiplex detection of early tubular injury biomarkers in diabetic kidney disease progression Wendi Cao, Sirui Yang, Zhenhua Zhao, Xuelin Chen, Tenglong Liu, Xinran Yang, Leshan Cai, Xiaozhe Lin, Xia Zhou, Qiaoxin Zhang Sensors and Actuators Reports.2026; 11: 100412. CrossRef
A Machine Learning-Based Prediction Model for Diabetic Kidney Disease in Korean Patients with Type 2 Diabetes Mellitus Kyung Ae Lee, Jong Seung Kim, Yu Ji Kim, In Sun Goak, Heung Yong Jin, Seungyong Park, Hyejin Kang, Tae Sun Park Journal of Clinical Medicine.2025; 14(6): 2065. CrossRef
Chronic Kidney Disease in Diabetes: A Clinical Practice Guideline Sheldon W. Tobe, Harpreet S. Bajaj, Navdeep Tangri, Rahul Jain, Thuy Pham, Valerie Beaudin, Phil McFarlane Canadian Journal of Diabetes.2025; 49(2): 73. CrossRef
Kidney failure risk equation (KFRE), A risk-based triage for nephrology referrals: A mixed-methods study at pre-implementation phase among healthcare providers Nur Raziana Rozi, Christine Shamala Selvaraj, Jia-Kai Tan, Zhan-Foong Lim, Noor Wahidah Nordin, Nuqman Hakimi Mazhar, Haris Hafizal, Hooi-Chin Beh, Quan-Hziung Lim, Ying-Guat Ooi, Adina Abdullah, Wan Ahmad Hafiz Wan Md Adnan, Pavai Sthaneswar, Soo-Kun Lim Primary Care Diabetes.2025; 19(6): 636. CrossRef
Construction and validation of a clinical prediction model for diabetic ketoacidosis Chen Xu, Xingwen Jiang, Quanan He, Peng Xu Frontiers in Medicine.2025;[Epub] CrossRef
External validation, recalibration, and clinical utility of the kidney failure risk equation in patients with advanced CKD: a nationwide retrospective cohort analysis in Peru Jessica Ivonne Bravo-Zúñiga, Percy Soto-Becerra, Edgar Juan Coila-Paricahua, Ricardo Chávez-Gómez, Eduardo Pérez-Tejada, Anselma Victoria Pardo-Villafranca, Lizbeth Carmen Arce-Gallo, Daysi Diaz-Obregón BMC Nephrology.2025;[Epub] CrossRef
Reprint of: Chronic Kidney Disease in Diabetes: A Clinical Practice Guideline Sheldon W. Tobe, Harpreet S. Bajaj, Navdeep Tangri, Rahul Jain, Thuy Pham, Valerie Beaudin, Phil McFarlane Canadian Journal of Diabetes.2025; 49: 7. CrossRef
Prevalence of diabetes and its associated factors in Cape Verde: an analysis of the 2020 WHO STEPS survey on non-communicable diseases risk factors Joshua Okyere, Castro Ayebeng, Kwamena Sekyi Dickson BMC Endocrine Disorders.2024;[Epub] CrossRef